US Edition
GLP-1 Drugs and Osteoporosis; HbA1c at the Dentist? New Obesity Med Guide
3 Articles
3 Articles
GLP-1 Drugs and Osteoporosis; HbA1c at the Dentist? New Obesity Med Guide
(MedPage Today) -- GLP-1 receptor agonists may increase the risk of bone and tendon injuries, as well as conditions like osteoporosis and gout, a retrospective study suggested. (Washington Post) Chairside HbA1c testing during routine dental visits...
GLP-1 treatments, popularized by drugs such as Ozempic or Wegovy, continue to deliver their secrets. If their benefits on weight loss and type 2 diabetes are widely recognized, a recent study raises a more delicate question: these molecules could expose some patients to an increased risk ... Read more The article Ozempic and similar medicines: a bone and joint risk now documented appeared first on Fredzone.
GLP-1 Side Effects May Increase Risks of Bone Fractures and Gout: Studies
Multiple recent studies have linked the popular drugs to losses in bone density, particularly for elderly patients. Two new studies suggest medications like Ozempic and Mounjaro may pose risks to bone health in older adults, raising concerns about prescribing the drugs to elderly patients. In one of the studies, researchers from Israel report that the widely …
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
